Find your next paid study

Wake Forest University Health SciencesNCT06945042

Actual pay is set by the research site.

Body Surface Gastric Mapping in Patients With Dyspeptic Symptoms: Recordings at Baseline and on Medical Therapy

Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with …

GastroparesisFunctional Dyspepsia

University of Auckland, New ZealandNCT06854120

Actual pay is set by the research site.

Phase 2

A Multi-center, Randomized (1:1), Controlled Phase II Trial of STIMULAN VG With Debridement and a Course of Systemic Antibiotics vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

The purpose of this trial is to assess the safety, tolerability and between-group effect size of STIMULAN VG (with debridement) and a course of systemic antibi…

Pressure Ulcer, Stage IVOsteomyelitis

Biocomposites LtdNCT06283979

~$75 – $2,800

Actual pay is set by the research site.

Phase 2

IIT2022-05-Sankar-BELIEVE: Phase II Study of Bevacizumab in Combination With Chemoimmunotherapy and Maintenance Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

This clinical trial aims to assess whether the addition of bevacizumab to atezolizumab and chemotherapy can improve response to treatment and progression-free …

Extensive-stage Small-cell Lung CancerLiver Metastases

B-cell Non-Hodgkins Lymphoma (B-NHL)

~$75 – $3,000

Actual pay is set by the research site.

Kamya SankarNCT05588388

Phase 1

A Phase 1 Study to Assess Safety and Tolerability of REGN5837, an Anti-CD22 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Odronextamab, an Anti-CD20 x Anti-CD3 Bispecific Monoclonal Antibody, in Patients With Aggressive B-Cell Non-Hodgkin Lymphomas (ATHENA-1)

This study is researching an experimental drug called REGN5837 in combination with another drug, odronextamab (called "study drug\[s\]"), in patients with rela…

Regeneron PharmaceuticalsNCT05685173

~$150 – $4,200

Actual pay is set by the research site.

Phase 1

A Phase 1, Multi-center, Single-dose, Open-label Study to Evaluate the Pharmacokinetics and Safety of Golcadomide (BMS-986369) in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function

The purpose of this study is to assess the pharmacokinetics and safety of golcadomide (BMS-986369) in matched healthy participants with normal renal function, …

Kidney Failure, Chronic

Bristol-Myers SquibbNCT07763418

~$500 – $11,250

Actual pay is set by the research site.

Strong Survivors: A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors

The investigators cancer rehabilitation/recovery program, Strong Survivor, has been designed to be delivered digitally, and while there are many such programs …

Mastectomy

University of California, San DiegoNCT07071896

Actual pay is set by the research site.

Lifting More Than Weights: Feasibility of Implementing a Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

The long-term goal of this project is to improve the implementation of tailored resistance exercise interventions for Appalachian breast cancer survivors. To a…

Breast CancerFatigue

West Virginia UniversityNCT06960720

Actual pay is set by the research site.

Imaging Oxidative Metabolism and Neurotransmitter Synthesis in the Human Brain

Investigators propose to develop hyperpolarized \[13C\]-labeled pyruvate as potential imaging probes to assess two essential in vivo processes in cerebral meta…

Brain Metabolism

University of Texas Southwestern Medical CenterNCT03849963

Actual pay is set by the research site.

Phase 1

A Phase 1, Randomized, Placebo-Controlled, First-in-Human, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered KT-579 in Healthy Adult Participants

This is a first-in-human study to evaluate safety and tolerability, pharmacokinetics, and pharmacodynamics of single and multiple dose levels of KT-579 in heal…

Healthy Participants

Kymera Therapeutics, Inc.NCT07412288

~$500 – $10,500

Actual pay is set by the research site.

Malignant Brain TumorGliomaCoping Skills

NeuroPathways: An Information and Support Intervention for Patients With Malignant Brain Tumors

This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed…

Massachusetts General HospitalNCT05976490

Actual pay is set by the research site.

Spinal FusionChronic Lower Back Pain

Utilizing Photobiomodulation Via Laser Diode Belts To Treat Chronic Lower Back Pain in Patients Who Have Undergone Spinal Fusion and Decompression Surgery

After spinal fusion and decompression surgery there is a possible risk of developing chronic back pain. After surgery there is typically inflammation around th…